Michael Karus

433 total citations
12 papers, 292 citations indexed

About

Michael Karus is a scholar working on Mechanical Engineering, Nephrology and Plant Science. According to data from OpenAlex, Michael Karus has authored 12 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Mechanical Engineering, 3 papers in Nephrology and 3 papers in Plant Science. Recurrent topics in Michael Karus's work include Parathyroid Disorders and Treatments (3 papers), Dialysis and Renal Disease Management (3 papers) and Agricultural Engineering and Mechanization (3 papers). Michael Karus is often cited by papers focused on Parathyroid Disorders and Treatments (3 papers), Dialysis and Renal Disease Management (3 papers) and Agricultural Engineering and Mechanization (3 papers). Michael Karus collaborates with scholars based in Germany, Poland and Austria. Michael Karus's co-authors include Markus Kaup, Dominik Walter Vogt, Richard Ammer, Markus Ketteler, Andrzej Więcek, Alexander R. Rosenkranz, Andreas Pasch, Jan Rekowski, Catharina A. Hartman and Andreas Reif and has published in prestigious journals such as Nephrology Dialysis Transplantation, Euphytica and European Child & Adolescent Psychiatry.

In The Last Decade

Michael Karus

11 papers receiving 261 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Karus Germany 8 146 83 61 50 48 12 292
Md Zahidul Islam Bangladesh 6 157 1.1× 54 0.7× 35 0.6× 26 0.5× 60 1.3× 13 308
Md Reajul Islam Bangladesh 6 194 1.3× 56 0.7× 30 0.5× 33 0.7× 61 1.3× 14 330
Md Emdad Sarker Bangladesh 4 131 0.9× 51 0.6× 23 0.4× 13 0.3× 52 1.1× 7 267
A T M Faiz Ahmed Bangladesh 5 136 0.9× 51 0.6× 23 0.4× 13 0.3× 53 1.1× 13 282
João P. Manaia Portugal 6 219 1.5× 55 0.7× 83 1.4× 48 1.0× 94 2.0× 9 330
Matthew Schwarzkopf Slovenia 10 88 0.6× 39 0.5× 52 0.9× 31 0.6× 50 1.0× 30 286
Camille Goudenhooft France 11 306 2.1× 140 1.7× 143 2.3× 31 0.6× 180 3.8× 21 481
Yalçın Çöpür Türkiye 10 259 1.8× 85 1.0× 61 1.0× 44 0.9× 164 3.4× 19 505
Wilton R. Goynes United States 11 144 1.0× 121 1.5× 24 0.4× 16 0.3× 66 1.4× 50 402
Jamie Hague Australia 6 214 1.5× 84 1.0× 73 1.2× 53 1.1× 93 1.9× 7 342

Countries citing papers authored by Michael Karus

Since Specialization
Citations

This map shows the geographic impact of Michael Karus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Karus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Karus more than expected).

Fields of papers citing papers by Michael Karus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Karus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Karus. The network helps show where Michael Karus may publish in the future.

Co-authorship network of co-authors of Michael Karus

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Karus. A scholar is included among the top collaborators of Michael Karus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Karus. Michael Karus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Egli-Spichtig, Daniela, Markus Ketteler, Andrzej Więcek, et al.. (2023). Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patients. Clinical Kidney Journal. 16(10). 1622–1633. 5 indexed citations
3.
Ketteler, Markus, Andrzej Więcek, Alexander R. Rosenkranz, et al.. (2022). Modified-release nicotinamide for the treatment of hyperphosphataemia in haemodialysis patients: 52-week efficacy and safety results of the phase 3 randomized controlled NOPHOS trial. Nephrology Dialysis Transplantation. 38(4). 982–991. 8 indexed citations
5.
Ketteler, Markus, Andrzej Więcek, Alexander R. Rosenkranz, et al.. (2020). Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis—A Randomized Clinical Trial. Kidney International Reports. 6(3). 594–604. 13 indexed citations
7.
Karus, Michael. (2004). European Hemp Industry 2002. 9(2). 93–101. 9 indexed citations
8.
Karus, Michael. (2004). First International Conference of the European Industrial Hemp Association (EIHA). 9(1). 117–127. 3 indexed citations
9.
Karus, Michael & Dominik Walter Vogt. (2004). European hemp industry: Cultivation, processing and product lines. Euphytica. 140(1-2). 7–12. 107 indexed citations
10.
Karus, Michael, et al.. (2003). Use of Natural Fibres in Composites in the German and Austrian Automotive Industry—Market Survey 2002. 8(2). 73–78. 12 indexed citations
11.
Karus, Michael. (2002). European Hemp Industry 2001. 7(2). 95–99. 11 indexed citations
12.
Karus, Michael & Markus Kaup. (2002). Natural Fibres in the European Automotive Industry. 7(1). 119–131. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026